当前位置: 首页 > 期刊 > 《中外医疗》 > 202012
编号:13483325
组织因子及其可溶性剪切体在结肠癌组织中的表达及临床意义(3)
http://www.100md.com 2020年4月25日 《中外医疗》 202012
     [參考文献]

    [1] Versteeg HH.Tissue Factor: Old and New Links with Cancer Biology[J].Semin Thromb Hemost,2015,41(7):747-755.

    [2] 胡丽超,周红,武标,等.c-Jun/AP-1在因子Ⅶa促进SW620细胞增殖和迁移中的激活及其调控作用[J].江苏医药,2013,39(7):764-766.

    [3] Graf C, Ruf W.Tissue factor asa mediator of coagulation and signaling in cancer and chronic inflammation[J].Thromb Res. 2018,164(1):S143-S147.

    [4] Hisada Y, Mackman N.TissueFactor and Cancer: Regulation, Tumor Growth, and Metastasis[J].Semin Thromb Hemost,2019,45(4):385-395.

    [5] Eriksson O,Asplund A,Hegde G,et al.A stromal cell popul ation in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression[J].Thromb Haemost,2016,116(6):1050-1059.

    [6] Clouston HW,Rees PA, Lamb R, et al.Effect of Tissue Factor on Colorectal Cancer Stem Cells[J].Anticancer Res,2018,38(5):2635-2642.

    [7] Wu M, Chen L, Xu T,et al.Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancertissues[J].Oncotarget,2017,16(32):53137-53145.

    [8] Rollin J, Regina S, Gruel Y.Tumor expression of alternatively spliced tissue factor is a prognostic marker in non-small cell lung cancer[J].J Thromb Haemost,2010,8(3):607-610.

    [9] Kocatürk B, Tieken C, Vreeken D, et al.Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression[J].J Thromb Haemost,2015,13(9):1683-1693.

    (收稿日期:2020-01-06), 百拇医药(胡丽超 李佳丽 杨占甲 王敬真 程自想 高凯)
上一页1 2 3